189 related articles for article (PubMed ID: 33132373)
1. Effects of the Ophthalmic Additive Mannitol on Antimicrobial Activity and Corneal Toxicity of Various Preservatives.
Inaba K; Minami M; Yamaguchi M; Goto R; Otake H; Kotake T; Nagai N
Chem Pharm Bull (Tokyo); 2020; 68(11):1069-1073. PubMed ID: 33132373
[TBL] [Abstract][Full Text] [Related]
2. Decrease in Corneal Damage due to Benzalkonium Chloride by the Addition of Mannitol into Timolol Maleate Eye Drops.
Nagai N; Yoshioka C; Tanino T; Ito Y; Okamoto N; Shimomura Y
J Oleo Sci; 2015; 64(7):743-50. PubMed ID: 26136174
[TBL] [Abstract][Full Text] [Related]
3. New Classes of Polycationic Compounds as Preservatives for Ophthalmic Formulations.
von Deylen D; Dreher C; Seidelmann O; Reichl S
Pharm Res; 2018 Nov; 36(1):11. PubMed ID: 30411196
[TBL] [Abstract][Full Text] [Related]
4. Influence of different additives and their concentrations on corneal toxicity and antimicrobial effect of benzalkonium chloride.
Onizuka N; Uematsu M; Kusano M; Sasaki H; Suzuma K; Kitaoka T
Cornea; 2014 May; 33(5):521-6. PubMed ID: 24619166
[TBL] [Abstract][Full Text] [Related]
5. Decrease in corneal damage due to benzalkonium chloride by the addition of sericin into timolol maleate eye drops.
Nagai N; Ito Y; Okamoto N; Shimomura Y
J Oleo Sci; 2013; 62(3):159-66. PubMed ID: 23470443
[TBL] [Abstract][Full Text] [Related]
6. [In vitro evaluation for corneal damages by anti-glaucoma combination eye drops using human corneal epithelial cell (HCE-T)].
Nagai N; Murao T; Oe K; Ito Y; Okamoto N; Shimomura Y
Yakugaku Zasshi; 2011; 131(6):985-91. PubMed ID: 21628988
[TBL] [Abstract][Full Text] [Related]
7. Effects of Benzalkonium Chloride and Preservative-Free Composition on the Corneal Epithelium Cells.
Kabashima K; Murakami A; Ebihara N
J Ocul Pharmacol Ther; 2020 Nov; 36(9):672-678. PubMed ID: 32552267
[No Abstract] [Full Text] [Related]
8. Antimicrobial activity of a new preservative for multiuse ophthalmic solutions.
Ghelardi E; Celandroni F; Gueye SA; Salvetti S; Campa M; Senesi S
J Ocul Pharmacol Ther; 2013; 29(6):586-90. PubMed ID: 23428175
[TBL] [Abstract][Full Text] [Related]
9. New Candidate Preservative in Ophthalmic Solution Instead of Benzalkonium Chloride: 1,3-Didecyl-2-methyl Imidazolium Chloride.
Iwasaki T; Uchiyama R; Nosaka K
Chem Pharm Bull (Tokyo); 2023; 71(7):552-557. PubMed ID: 37394604
[TBL] [Abstract][Full Text] [Related]
10. Acute cytotoxic effects of marketed ophthalmic formulations on human corneal epithelial cells.
Hakkarainen JJ; Reinisalo M; Ragauskas S; Seppänen A; Kaja S; Kalesnykas G
Int J Pharm; 2016 Sep; 511(1):73-78. PubMed ID: 27374205
[TBL] [Abstract][Full Text] [Related]
11. N-hydroxymethylglycinate with EDTA is an efficient eye drop preservative with very low toxicity: an in vitro comparative study.
Cristaldi M; Olivieri M; Lupo G; Anfuso CD; Pezzino S; Rusciano D
Cutan Ocul Toxicol; 2018 Mar; 37(1):71-76. PubMed ID: 28658977
[TBL] [Abstract][Full Text] [Related]
12. Ophthalmic preservatives: focus on polyquaternium-1.
Rolando M; Crider JY; Kahook MY
Expert Opin Drug Deliv; 2011 Nov; 8(11):1425-38. PubMed ID: 21905766
[TBL] [Abstract][Full Text] [Related]
13. Optimising concentrations of antimicrobial agents in pharmaceutical preparations: Case of an oral solution of glycerol and an ophthalmic solution containing cysteamine.
Chan Hew Wai A; Becasse P; Tworski S; Pradeau D; Planas V
Ann Pharm Fr; 2014 Nov; 72(6):415-21. PubMed ID: 25438652
[TBL] [Abstract][Full Text] [Related]
14. The cytotoxic effects of preserved and preservative-free prostaglandin analogs on human corneal and conjunctival epithelium in vitro and the distribution of benzalkonium chloride homologs in ocular surface tissues in vivo.
Pellinen P; Huhtala A; Tolonen A; Lokkila J; Mäenpää J; Uusitalo H
Curr Eye Res; 2012 Feb; 37(2):145-54. PubMed ID: 22049909
[TBL] [Abstract][Full Text] [Related]
15. A Nanoparticle-Based Ophthalmic Formulation of Dexamethasone Enhances Corneal Permeability of the Drug and Prolongs Its Corneal Residence Time.
Nagai N; Nakazawa Y; Ito Y; Kanai K; Okamoto N; Shimomura Y
Biol Pharm Bull; 2017; 40(7):1055-1062. PubMed ID: 28674248
[TBL] [Abstract][Full Text] [Related]
16. [Optimization of benzalkonium chloride concentration in 0.0015% tafluprost ophthalmic solution from the points of ocular surface safety and preservative efficacy].
Asada H; Takaoka-Shichijo Y; Nakamura M; Kimura A
Yakugaku Zasshi; 2010 Jun; 130(6):867-71. PubMed ID: 20519865
[TBL] [Abstract][Full Text] [Related]
17. A nanoparticle formulation reduces the corneal toxicity of indomethacin eye drops and enhances its corneal permeability.
Nagai N; Ito Y; Okamoto N; Shimomura Y
Toxicology; 2014 May; 319():53-62. PubMed ID: 24598350
[TBL] [Abstract][Full Text] [Related]
18. Medical devices biocompatibility assessment on HCE: Evidences of delayed cytotoxicity of preserved compared to preservative free eye drops.
Meloni M; Balzaretti S; Ceriotti L
Regul Toxicol Pharmacol; 2019 Aug; 106():81-89. PubMed ID: 31039384
[TBL] [Abstract][Full Text] [Related]
19. Multiple endpoint analysis of BAC-preserved and unpreserved antiallergic eye drops on a 3D-reconstituted corneal epithelial model.
Pauly A; Brasnu E; Riancho L; Brignole-Baudouin F; Baudouin C
Mol Vis; 2011 Mar; 17():745-55. PubMed ID: 21437201
[TBL] [Abstract][Full Text] [Related]
20. The effect of ophthalmic preservatives on the healing rate of the rabbit corneal epithelium after keratectomy.
Collin HB; Grabsch BE
Am J Optom Physiol Opt; 1982 Mar; 59(3):215-22. PubMed ID: 6803596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
